Karin P. S.
- Country
- Sweden
- Department
- Dermatologiska Kliniken
Research Overview
Data & Insights
Has run more than one trial at 47 of 88 partner sites.
Specializations
Cutaneous Lupus Research
The investigator specializes in studying cutaneous lupus erythematosus (CLE), with particular focus on its subacute and chronic forms. Their research encompasses the evaluation of novel therapeutic approaches for patients whose condition is refractory to conventional treatments.
- Subacute Cutaneous Lupus Erythematosus (SCLE)
- Chronic Cutaneous Lupus Erythematosus (CCLE)
The investigator explores treatments for patients with or without systemic manifestations of the disease.
Treatment Innovation
Central to their research is the investigation of litifilimab (BIIB059), examining its potential as a therapeutic option for CLE patients who have not responded adequately to antimalarial therapy.
- Long-term Safety Studies
- Treatment Efficacy Assessment
- Antimalarial-Refractory Cases
Their work focuses on evaluating both immediate and extended therapeutic outcomes in treatment-resistant cases.
Clinical Assessment
The investigator utilizes advanced clinical assessment tools to measure treatment effectiveness in cutaneous lupus patients.
- CLA-IGA-R Scoring System
- CLASI-A Assessment
- Skin Disease Activity Measurement
Their research implements standardized evaluation methods to track disease progression and treatment response.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.